• LAST PRICE
    0.0128
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0120/ 100
  • Ask / Lots
    0.0150/ 100
  • Open / Previous Close
    --- / 0.0128
  • Day Range
    ---
  • 52 Week Range
    Low 0.0116
    High 0.0600
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.01475
TimeVolumeXCRT
09:32 ET20000.0145
09:44 ET200000.0145
09:53 ET125000.01485
09:55 ET75000.0147
10:08 ET50000.01485
10:09 ET26670.01485
10:11 ET10000.01485
10:13 ET70000.015
11:23 ET200000.0147
11:38 ET10000.01485
11:48 ET125000.0147
11:57 ET1000.0136
11:59 ET10000.0136
12:14 ET10000.01365
12:15 ET20000.014055
12:30 ET34000.01365
01:38 ET10000.01422
02:03 ET2288900.0124
02:05 ET2060180.0137
02:07 ET10000.015
03:24 ET201000.0122
03:30 ET50000.0124
03:32 ET260000.012325
03:35 ET10000.0133
04:00 ET8000.01278
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesXCRT
Xcelerate Inc
5.5M
-9.3x
---
United StatesKDLY
Kindly MD Inc
5.1M
-1.8x
---
United StatesGRST
Ethema Health Corp
4.6M
2.7x
---
United StatesGENE
Genetic Technologies Ltd
6.3M
-0.4x
---
United StatesSYRA
Syra Health Corp
4.0M
-0.6x
---
United StatesMYNZ
Mainz Biomed NV
4.8M
-0.2x
---
As of 2024-11-08

Company Information

Xcelerate, Inc. seeks to acquire technology/healthcare business. The Company’s business plan encompasses three separate but related businesses within the medical, health and wellness sectors, including owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses; formulation, packaging and marketing of over the counter, clinically tested skin care products, and development of virtual health technology to assist patients in developing countries, initially in Africa, to provide for their population to obtain medical care by extending the reach of physicians through the use of that technology.

Contact Information

Headquarters
110 Renaissance CircleMAULDIN, SC, United States 29662
Phone
954-575-2252
Fax
---

Executives

Chief Executive Officer, Director
Michael O'Shea
Chief Scientific Officer
Anja Glisovic
Director
Steve Gravely
Director
Jon Wilken

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$5.5M
Revenue (TTM)
$4.0M
Shares Outstanding
432.4M
Xcelerate Inc does not pay a dividend.
Beta
3.07
EPS
$0.00
Book Value
$0.00
P/E Ratio
-9.3x
Price/Sales (TTM)
1.4
Price/Cash Flow (TTM)
---
Operating Margin
-3.38%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.